Mergers and Acquisitions

We handle some of the largest, most complex and demanding transactions in the united states and around the world. 

  • AstraZeneca (7 billion). We advised AstraZeneca on its expansion of its alliance with Bristol-Myers Squibb (BMS) through BMS’ acquisition of Amylin Pharmaceuticals, a San Diego, California-based biopharmaceutical company. 

  • EQT Partners (2.2 billion). We advised EQT Partners, a Swedish private equity firm, on its sale of Dako, a Danish tissue-based diagnostics company, to Agilent Technologies, a Santa Clara, California–based provider of measurement technology for chemical analysis and life sciences applications. 

  • Edwards Group (1.6 billion). We have advised Edwards Group, a United Kingdom based developer and manufacturer of sophisticated vacuum products, abatement systems and other related value-added services, on its $1.6 billion acquisition, pending specific earnouts, by Atlas Copco, a Swedish manufacturer of compressors, expanders and air treatment systems, construction and mining equipment, power tools and assembly systems. 

  • Taylor Wimpey (955 million). We advised Taylor Wimpey, a homebuilder, in connection with the sale of its US and Canadian business to TMM Holdings, a partnership controlled by certain investment funds affiliated with TPG Capital, certain investment funds affiliated with Oaktree Capital Management and JH Investments. 

  • Delonex Energy (700 million). We have advised Delonex Energy, a new, world-class energy exploration and production company focused on Central and East Africa with headquarters in London, in connection with a $700 million investment by an affiliate of Warburg Pincus, a global private equity firm with more than $40 billion in assets under management. 

  • ARM (350 million). We advised ARM Holdings, a United Kingdom developer and supplier of semiconductor intellectual property, on its leading participation in a consortium of major technology companies affiliated with Allied Security Trust that acquired the rights to MIPS Technologies’ patent portfolio for $350 million, of which ARM will contribute $168 million. The MIPS patent portfolio includes five-hundred patent applications covering microprocessor design, system-on-chip design and other related technology fields.